意大利高级帕金森病治疗模式:来自多中心观察研究的结果
Fabrizio Stocchi1, Paolo Barone2, Roberto Ceravolo3
1Department of Neurology, University San Raffaele Roma and IRCCS San Raffaele, Rome, Italy.
Annals of medicine
|March 5, 2026
概括
通过更新的治疗方法,管理帕金森病 (PD) 的波动是可以实现的. 个性化策略和新药物有助于在晚期PD患者中保持疾病稳定.
科学领域:
- 神经学 神经学
- 运动障碍 运动障碍
- 药理学 药理学是指药理学的学科.
背景情况:
- 利沃多巴是帕金森病 (PD) 的主要治疗方法,但长期使用会导致运动波动和动力障碍,影响生活质量.
- 对于晚期PD的波动的管理策略没有得到充分的记录.
- 帕金森病波动治疗途径 (PD-FPA) 的研究旨在描述高级PD的当前波动管理.
研究的目的:
- 描述治疗途径,以管理晚期帕金森病患者的波动.
- 在患有PD波动的患者中,在3年内记录治疗变化和药物使用情况.
主要方法:
- 意大利的一项多中心观察性研究,涉及296名患有PD的患者,患者在10-15年前被诊断出患有PD并经历了至少2年的波动.
- 数据是在基线 (T0) 收集的,在6个月 (T1) 和12个月 (T2) 收集的前性数据,以及T0.0前1-2年的回顾性数据.
- 包括患者特征,PD阶段,波动状态和治疗方案.
主要成果:
- 患者 (平均年龄68岁) 在PD阶段在3年内总体稳定.
- 多巴胺激动剂的使用减少了,而catechol-O-methyltransferase抑制剂的使用显著增加,其中萨菲纳米德和奥皮卡显示出最大的收益.
- 大约50%的T0患者和30%的T1/T2患者经历了治疗变化,主要是由于波动.
结论:
- 在具有波动的长期PD中,使用非侵入性治疗是可行的稳定疾病管理.
- 精确的治疗调整和采用新一代附加药物的个性化策略对于有效的管理至关重要.
关键词:
这是一种COMT抑制剂.这是一种MAOB抑制剂.帕金森病是帕金森病的一种疾病.运动障碍症 运动障碍症波动的波动是指波动的波动利沃多帕 (levodopa) 是一种可以使用的药物.这种药物是opicapone.沙菲纳胺是什么 沙菲纳胺磨损-脱落-脱落,这是一个很好的方法.更多相关视频
07:43Immunohistochemical Visualization of Hippocampal Neuron Activity After Spatial Learning in a Mouse Model of Neurodevelopmental Disorders
Published on: May 12, 2015
11.9K
09:49A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020
10.5K
相关概念视频
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...